UNH Franklin Pierce School of Law Introduces Innovative JD Specialization

UNH Franklin Pierce School of Law Expands Legal Education Offerings

In an exciting development for students and professionals alike, the University of New Hampshire Franklin Pierce School of Law is broadening its legal education framework with the introduction of a new concentration in Health and Life Sciences Law, set to launch in the fall of 2025. This initiative is designed to complement the school’s existing concentration in Intellectual Property (IP), Technology, and Information Law.

Key Highlights of the New Concentration

This new curriculum will enable non-residential JD students to delve into the multifaceted legal challenges that arise within healthcare, life sciences, and related fields. It aims to provide a comprehensive understanding of the issues surrounding the development, distribution, and regulation of biological products, which include biotech and pharmaceuticals.

Curriculum Overview

The Health and Life Sciences Law curriculum is meticulously designed to cater to the needs of today’s legal landscape. It will cover the interconnected domains of business, healthcare delivery, ethics, IP, and regulatory planning, ensuring that graduates emerge as skilled professionals equipped to navigate the complexities of legal practices in these sectors.

Innovative Learning Approach

Through this program, students will explore various essential topics, ultimately training to become subject-matter experts and strategic thinkers in their fields. The incorporation of experiential learning alongside traditional coursework ensures that graduates can effectively contribute to their organizations from day one.

Faculty Insights

Professor Lucy Hodder, the director of the Health and Life Sciences programs, shares her enthusiasm about the new concentration. She expresses, "We have a tradition of innovation at UNH Franklin Pierce and in our health law and policy program. Incorporating critical legal issues facing patients, providers, and businesses in the drug and device industry is vital for our educational framework." Hodder emphasizes the aim to develop practical pathways for sustainable solutions in the health and life sciences sector.

Meeting Industry Demand

The mostly online Hybrid JD program is crafted for professionals who already have experience in fields such as IP, technology, healthcare, and life sciences. The increasing need for attorneys who possess expertise in IP and life sciences law is evident across numerous industries, including healthcare, tech, biopharma, and even governmental organizations.

Employer Expectations and Graduate Preparedness

As the legal marketplace evolves, employers are on the lookout for graduates who can quickly adapt to industry demands and bring specialized knowledge to the table. Dean Megan Carpenter of UNH Franklin Pierce acknowledges this trend, stating, "We have led the way in non-residential, specialized legal education for more than five years, and we continue to adapt our programs to prepare the next generation of legal leaders in the health and life sciences sectors."

Program Structure and Features

The American Bar Association-approved non-residential JD program, which began in the fall of 2019, allows students to maintain their professional responsibilities while pursuing their degrees. With only 3-5 days of residency each quarter, participants benefit from a flexible learning structure designed to accommodate busy lifestyles.

Comprehensive Support and Resources

The JD program is structured to span 10 semesters over approximately 3.5 years, emphasizing year-round learning. Students benefit from full-time faculty, extensive academic support, and a robust curriculum geared toward success in their chosen legal fields. For further details, prospective students can visit the official UNH Franklin Pierce School of Law website.

About the University of New Hampshire Franklin Pierce School of Law

Accredited by the American Bar Association, UNH Franklin Pierce School of Law has built a prestigious reputation over the past 50 years, especially in the realms of IP and technology law. This legacy is complemented by a vast network of alumni thriving across the globe.

Frequently Asked Questions

What new focus does UNH Franklin Pierce School of Law have?

UNH Franklin Pierce School of Law is introducing a new concentration in Health and Life Sciences Law.

Who is this new specialization intended for?

This specialization is designed for professionals in fields related to IP, technology, healthcare, and life sciences.

How long is the JD program expected to last?

The program is structured over approximately 3.5 years, divided into 10 semesters.

What is the format of the Hybrid JD program?

The Hybrid JD program is primarily online, requiring limited in-person residency, making it flexible for working professionals.

What support is available to students?

Students receive extensive support, including faculty resources, academic assistance, and dedicated services to help them succeed.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. If any of the material offered here is inaccurate, please contact us for corrections.